Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.001
▾0.00 (0.00%)
Last trade: 17/04, 9:54AM
Market cap
$6.10m
Market closed
Talk to Medibio Limited directly.
Sign up to their Investor Hub for direct access to the Medibio Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Medibio Limited (MEB, formerly BioProspect Limited) is a medical technology company developing a new objective test to assist in the diagnosis of depression, other mental health disorders and chronic stress. This tests utilise circadian heart rate variability. The technology is based on the scientific finding that circadian heart rate variability is a sensitive measure for depression and other mental health disorders and chronic stress Former Names Bioprospect Limited (BPO), 28/11/2014
Address
Level 4/100 Albert Rd, South Melbourne VIC 3205, Australia
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.001
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets